BioSpace News Archive

Deals

Editas Makes Good on Portfolio Reprioritization with Shoreline Deals (Updated)

Editas announced the sale of its iPSC-derived iNK programs to Shoreline Biosciences. Shoreline also licensed Editas’ SLEEK technology.

January 19, 2023
·
2 min read
·
Hayley Shasteen
Business

Jazz’s $375M Investment in Zymeworks Paying Off in GI Cancer

Jazz Pharmaceuticals and Zymeworks announced results from a Phase II trial of the latter’s HER2-targeted antibody for metastatic gastroesophageal adenocarcinoma.

January 19, 2023
·
1 min read
·
Kate Goodwin
Drug Development

Roche’s Tecentriq/Avastin Combo Scores a First in Liver Cancer

Roche’s Tecentriq (atezolizumab) combined with Avastin (bevacizumab) met the primary efficacy endpoint in early-stage hepatocellular carcinoma in the Phase III IMbrave050 study.

January 19, 2023
·
2 min read
·
Tristan Manalac
Deals

bluebird Seeks Funding Through 2024 with New Public Offering

bluebird bio, Inc. is expecting gross proceeds of $120 million with its newly announced public offering of 20,000,000 shares.

January 19, 2023
·
1 min read
·
Hayley Shasteen
Drug Development

J&J Shuts Down Second HIV Vaccine Trial in as Many Years

Johnson & Johnson discontinued the Phase III trial of an investigational HIV vaccine regimen Wednesday after an independent review showed it was ineffective at preventing disease.

January 19, 2023
·
2 min read
·
Tristan Manalac
Business

DM Clinical Research Opens New Research Site in Boston Area

DM Clinical Research, a national network of clinical trial sites, has opened its first research location in the Boston metropolitan area and Massachusetts.

January 19, 2023
·
3 min read
Drug Development

Renibus Therapeutics Announces Oral Presentation on RBT-1 Phase 2 Results at 2023 Society of Critical Care Medicine (SCCM) Meeting

Renibus Therapeutics today announced that an oral presentation will be delivered on the positive results of RBT-1 from a Phase 2 Study at the Society for Critical Care Medicine (SCCM) 2023 Critical Care Congress at the Moscone Center in San Francisco, CA from January 21- 24, 2023.

January 19, 2023
·
6 min read
Pharm Country

NICE Recommends Reimbursement for Translarna™

PTC Therapeutics, Inc. announced that the National Institute for Health and Care Excellence has issued a Final Evaluation Document recommending Translarna™ for reimbursement and use across the National Health Service in England and Wales.

January 19, 2023
·
7 min read
Biotech Beach

SetPoint Medical Announces $80M Preferred Stock Financing to Advance Company’s Novel Treatment for Autoimmune Diseases

SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, today announced an $80 million preferred stock financing co-led by new investors Norwest Venture Partners and Viking Global Investors.

January 19, 2023
·
3 min read
Business

Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023

Twist Bioscience Corporation today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, 2023.

January 19, 2023
·
2 min read